Neurotoxic Mode of Action of Artemisinin
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Saved in:
Published in | Antimicrobial Agents and Chemotherapy Vol. 46; no. 3; pp. 821 - 827 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.03.2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
---|---|
AbstractList | We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell cultures (G. Schmuck and R. K. Haynes, Neurotoxicity Res. 2:37-49, 2000). Here, we probe possible mechanisms of this brain stem-specific neurodegeneration, in which artemisinin-sensitive neuronal brain stem cell cultures are compared with nonsensitive cultures (cortical neurons, astrocytes). Effects on the cytoskeleton of brain stem cell cultures, but not that of cortical cell cultures, were visible after 7 days. However, after a recovery period of 7 days, this effect also became visible in cortical cells and more severe in brain stem cell cultures. Neurodegeneration appears to be induced by effects on intracellular targets such as the cytoskeleton, modulation of the energy status by mitochondrial or metabolic defects, oxidative stress or excitotoxic events. Artemisinin reduces intracellular ATP levels and the potential of the inner mitochondrial membrane below the cytotoxic concentration range in all three cell cultures, with these effects being most dominant in the brain stem cultures. Surprisingly, there were substantial effects on cortical neurons after 7 days and on astrocytes after 1 day. Artemisinin additionally induces oxidative stress, as observed as an increase of reactive oxygen species and of lipid peroxidation in both neuronal cell types. Interestingly, an induction of expression of AOE was only seen in astrocytes. Here, manganese superoxide dismutase (MnSOD) expression was increased more than 3-fold and catalase expression was increased more than 1.5-fold. In brain stem neurons, MnSOD expression was dose dependently decreased. Copper-zinc superoxide dismutase and glutathione peroxidase, two other antioxidant enzymes that were investigated, did not show any changes in their mRNA expression in all three cell types after exposure to artemisinin. ABSTRACT We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell cultures (G. Schmuck and R. K. Haynes, Neurotoxicity Res. 2:37-49, 2000). Here, we probe possible mechanisms of this brain stem-specific neurodegeneration, in which artemisinin-sensitive neuronal brain stem cell cultures are compared with nonsensitive cultures (cortical neurons, astrocytes). Effects on the cytoskeleton of brain stem cell cultures, but not that of cortical cell cultures, were visible after 7 days. However, after a recovery period of 7 days, this effect also became visible in cortical cells and more severe in brain stem cell cultures. Neurodegeneration appears to be induced by effects on intracellular targets such as the cytoskeleton, modulation of the energy status by mitochondrial or metabolic defects, oxidative stress or excitotoxic events. Artemisinin reduces intracellular ATP levels and the potential of the inner mitochondrial membrane below the cytotoxic concentration range in all three cell cultures, with these effects being most dominant in the brain stem cultures. Surprisingly, there were substantial effects on cortical neurons after 7 days and on astrocytes after 1 day. Artemisinin additionally induces oxidative stress, as observed as an increase of reactive oxygen species and of lipid peroxidation in both neuronal cell types. Interestingly, an induction of expression of AOE was only seen in astrocytes. Here, manganese superoxide dismutase (MnSOD) expression was increased more than 3-fold and catalase expression was increased more than 1.5-fold. In brain stem neurons, MnSOD expression was dose dependently decreased. Copper-zinc superoxide dismutase and glutathione peroxidase, two other antioxidant enzymes that were investigated, did not show any changes in their mRNA expression in all three cell types after exposure to artemisinin. Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC |
Author | Regine Kahl Elke Roehrdanz Richard K. Haynes Gabriele Schmuck |
AuthorAffiliation | Pharma Research Center, Bayer AG, D-42096, Wuppertal, 1 Department of Toxicology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany, 3 Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 2 |
AuthorAffiliation_xml | – name: Pharma Research Center, Bayer AG, D-42096, Wuppertal, 1 Department of Toxicology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany, 3 Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 2 |
Author_xml | – sequence: 1 givenname: Gabriele surname: SCHMUCK fullname: SCHMUCK, Gabriele organization: Pharma Research Center, Bayer AG, 42096, Wuppertal, South Africa – sequence: 2 givenname: Elke surname: ROEHRDANZ fullname: ROEHRDANZ, Elke organization: Pharma Research Center, Bayer AG, 42096, Wuppertal, South Africa – sequence: 3 givenname: Richard K surname: HAYNES fullname: HAYNES, Richard K organization: Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay Kowloon, Hong-Kong – sequence: 4 givenname: Regine surname: KAHL fullname: KAHL, Regine organization: Department of Toxicology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13499427$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11850267$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtPGzEUhS1EBYH2J4CyadXNDH4_FiyiqC-Jlk27tu54PMRoYoM908e_r9NE0K66sOwrf-ce3-MzdBxT9AhdENwSQvXVarVuuWxZqylpNFUtxZgeoQXBRjdSGHmMFhhL2XCN-Sk6K-Ue11oYfIJOCdECU6kW6O0XP-c0pZ_BLT-n3i_TsFy5KaT455Qnvw0lxBBfohcDjMW_Ouzn6Nv7d1_XH5ub2w-f1qubBoRWUyMABCWckEGxznS17CV1ous7pzF4ZgboYNCqZ4YwwNz5QRrRaSU98Z3H7Bxd7_s-zN3W987HKcNoH3LYQv5lEwT7700MG3uXvltCFdeq6t8c9Dk9zr5Mtg7g_DhC9GkulmgqhSY7UOxBl1Mp2Q9PHgTbXcS2Rmy5tMzWiOtSdhdx1dG9DsqW2vs051jz-K_o8u-pnq0OH1GB1wcAioNxyBBdKM8c48ZwuuOWe24T7jY_Qva2PsMCuCdT9huqJKCf |
CODEN | AACHAX |
CitedBy_id | crossref_primary_10_1074_jbc_M610375200 crossref_primary_10_3389_fncel_2018_00108 crossref_primary_10_1128_AAC_00373_07 crossref_primary_10_1016_j_toxlet_2006_09_002 crossref_primary_10_1016_j_neuron_2019_01_001 crossref_primary_10_1016_j_semcancer_2017_01_006 crossref_primary_10_1177_0960327114532385 crossref_primary_10_1016_j_actatropica_2009_08_002 crossref_primary_10_1016_j_ejmech_2018_12_007 crossref_primary_10_1016_j_genhosppsych_2008_10_004 crossref_primary_10_1016_j_bcp_2011_06_002 crossref_primary_10_1002_cmdc_201600011 crossref_primary_10_1158_0008_5472_CAN_07_2970 crossref_primary_10_1155_2012_247597 crossref_primary_10_1021_acschemneuro_1c00120 crossref_primary_10_1002_cmdc_200600240 crossref_primary_10_1002_ptr_5958 crossref_primary_10_1002_ana_25028 crossref_primary_10_1002_cmdc_200900342 crossref_primary_10_1016_j_mcn_2021_103624 crossref_primary_10_1021_acsabm_8b00358 crossref_primary_10_1002_cmdc_201700600 crossref_primary_10_1016_S0020_7519_02_00194_7 crossref_primary_10_3109_15376516_2011_552534 crossref_primary_10_1016_j_cbi_2003_12_005 crossref_primary_10_3923_ajb_2011_373_383 crossref_primary_10_1016_j_ijpddr_2017_05_002 crossref_primary_10_1128_AAC_01553_13 crossref_primary_10_1016_j_ejmech_2016_07_027 crossref_primary_10_1021_cr500543f crossref_primary_10_1016_j_ijpara_2006_07_011 crossref_primary_10_1016_j_toxlet_2006_06_001 crossref_primary_10_1002_ange_200503071 crossref_primary_10_3109_10408441003610571 crossref_primary_10_1016_S0161_813X_02_00096_7 crossref_primary_10_14336_AD_2019_0813 crossref_primary_10_1586_eri_09_53 crossref_primary_10_1002_cmdc_201200383 crossref_primary_10_1080_02772240802445522 crossref_primary_10_1002_ana_20620 crossref_primary_10_1128_AAC_00375_11 crossref_primary_10_1186_1475_2875_7_179 crossref_primary_10_1016_j_tet_2018_04_027 crossref_primary_10_1021_acs_biomac_7b00852 crossref_primary_10_1016_j_ijbiomac_2021_01_072 crossref_primary_10_1016_j_molmed_2006_03_005 crossref_primary_10_1016_j_trstmh_2006_09_001 crossref_primary_10_1002_cbic_200400366 crossref_primary_10_5897_AJPP2017_4777 crossref_primary_10_1002_cmdc_201000225 crossref_primary_10_1016_j_trstmh_2006_10_003 crossref_primary_10_1002_ardp_201600335 crossref_primary_10_1155_2013_965046 crossref_primary_10_1002_anie_200503071 crossref_primary_10_1016_j_medmal_2019_02_005 crossref_primary_10_1016_j_pt_2006_05_011 crossref_primary_10_5530_ax_2011_1_7 crossref_primary_10_3390_molecules23071713 crossref_primary_10_3390_pharmaceutics13122066 crossref_primary_10_1016_j_etap_2016_03_018 crossref_primary_10_3390_ijms20112680 crossref_primary_10_1517_13543776_13_11_1763 crossref_primary_10_1002_anie_200352343 crossref_primary_10_1002_bdrb_20282 crossref_primary_10_1016_j_tox_2007_08_084 crossref_primary_10_1016_j_vetpar_2011_12_020 crossref_primary_10_1016_j_phrs_2018_09_002 crossref_primary_10_1186_1471_2202_10_88 crossref_primary_10_2174_1568026619666190412104042 crossref_primary_10_1007_s11250_010_9771_3 crossref_primary_10_1073_pnas_2008695117 crossref_primary_10_1086_502658 crossref_primary_10_1186_s12936_015_0682_7 crossref_primary_10_1007_s40263_019_00649_9 crossref_primary_10_1186_1475_2875_9_227 crossref_primary_10_1016_j_ejphar_2022_175467 crossref_primary_10_1002_ange_200352343 crossref_primary_10_1016_j_etap_2005_07_006 crossref_primary_10_1016_j_tips_2008_07_004 crossref_primary_10_1016_S0140_6736_06_67958_0 crossref_primary_10_3390_molecules21101331 |
Cites_doi | 10.7164/antibiotics.52.880 10.1056/NEJM199607113350202 10.1006/taap.1997.8344 10.1016/0024-3205(95)00055-B 10.1016/S0021-9258(17)43645-3 10.2165/00002018-199512060-00003 10.4269/ajtmh.1997.56.390 10.1007/s004290050326 10.4269/ajtmh.1999.60.547 10.1177/074823379601200507 10.1016/S0361-9230(97)00339-0 10.1073/pnas.83.2.313 10.1080/00034983.1996.11813022 10.1080/00034983.1995.11812975 10.1126/science.3887571 10.1016/0014-5793(92)80198-P 10.1093/nar/15.16.6746 10.1111/j.1440-1681.1995.tb02015.x 10.1007/BF03033326 10.1056/NEJM199607113350201 10.1006/taap.1995.1163 10.1093/nar/15.23.10070 10.1016/S0021-9258(18)54242-3 10.1016/S0140-6736(84)92457-7 10.1016/S0014-5793(00)01592-1 |
ContentType | Journal Article |
Copyright | 2002 INIST-CNRS Copyright © 2002 American Society for Microbiology Copyright © 2002, American Society for Microbiology 2002 |
Copyright_xml | – notice: 2002 INIST-CNRS – notice: Copyright © 2002 American Society for Microbiology – notice: Copyright © 2002, American Society for Microbiology 2002 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7U7 C1K 5PM |
DOI | 10.1128/AAC.46.3.821-827.2002 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE CrossRef Toxicology Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology Biology |
EISSN | 1098-6596 |
EndPage | 827 |
ExternalDocumentID | 10_1128_AAC_46_3_821_827_2002 0608 11850267 13499427 aac_46_3_821 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- .55 .GJ 08R 0R~ 23M 2WC 39C 3O- 4.4 53G 5GY 5RE 5VS 6J9 8W4 AAPBV ABFLS ACGFO ADBBV ADGIM AENEX AFMIJ AGNAY AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CS3 DIK E3Z EBS EJD F5P FRP GX1 H13 HH5 HYE HZ~ H~9 IQODW J5H K-O KQ8 L7B LSO MVM NEJ O9- OK1 P2P RHF RHI RNS RPM RSF TR2 UHB VH1 W2D W8F WH7 WHG WOQ X7M X7N XOL Y6R ZA5 ZGI ZXP ~A~ CGR CUY CVF ECM EIF NPM - 0R 55 A ADACO ADBIT BXI GJ HZ AAYXX CITATION 7TK 7U7 C1K 5PM |
ID | FETCH-LOGICAL-a587t-5aa521411f73b9b5aad62c5bdbc80ae39fabaf87d3913a04cef695b876e1ebe03 |
IEDL.DBID | RPM |
ISSN | 0066-4804 |
IngestDate | Tue Sep 17 21:04:08 EDT 2024 Sat Aug 17 02:39:51 EDT 2024 Thu Sep 12 16:51:24 EDT 2024 Tue Dec 28 13:59:20 EST 2021 Sun Oct 13 09:37:39 EDT 2024 Thu Nov 24 18:22:06 EST 2022 Wed May 18 15:27:01 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Glutathione peroxidase Antimalarial Oxidative stress Enzyme Toxicity Artemisinin Lipids Superoxide dismutase Gene expression Cerebral disorder Neuron Peroxidases Parasiticid Central nervous system disease Cytoskeleton Oxidoreductases Mechanism of action Peroxidation |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a587t-5aa521411f73b9b5aad62c5bdbc80ae39fabaf87d3913a04cef695b876e1ebe03 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Present address: Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), 53113 Bonn, Germany. Corresponding author. Mailing address: BAYER AG, Pharma Research Centre, Aprather Weg, D-42096 Wuppertal, Germany. Phone: 0049 202 368830. Fax: 0049 202 364137. E-mail: GABRIELE.SCHMUCK.GS@bayer-ag.de. |
OpenAccessLink | https://europepmc.org/articles/pmc127487?pdf=render |
PMID | 11850267 |
PQID | 18265817 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_18265817 pubmed_primary_11850267 pascalfrancis_primary_13499427 pubmedcentral_primary_oai_pubmedcentral_nih_gov_127487 crossref_primary_10_1128_AAC_46_3_821_827_2002 asm2_journals_10_1128_AAC_46_3_821_827_2002 highwire_asm_aac_46_3_821 |
PublicationCentury | 2000 |
PublicationDate | 2002-03-01 |
PublicationDateYYYYMMDD | 2002-03-01 |
PublicationDate_xml | – month: 03 year: 2002 text: 2002-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Antimicrobial Agents and Chemotherapy |
PublicationTitleAbbrev | AAC |
PublicationTitleAlternate | Antimicrob Agents Chemother |
PublicationYear | 2002 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_27_2 (e_1_3_2_34_2) 1998; 24 (e_1_3_2_14_2) 1998; 45 (e_1_3_2_17_2) 1987; 15 (e_1_3_2_2_2) 1995; 22 e_1_3_2_40_2 (e_1_3_2_44_2) 1995; 36 (e_1_3_2_6_2) 1998; 58 (e_1_3_2_36_2) 1996; 12 e_1_3_2_23_2 (e_1_3_2_45_2) 1996; 335 (e_1_3_2_32_2) 1995; 12 (e_1_3_2_9_2) 1984; 259 (e_1_3_2_5_2) 1994; 88 (e_1_3_2_24_2) 1992 (e_1_3_2_42_2) 1999; 52 (e_1_3_2_31_2) 2000; 201 (e_1_3_2_37_2) 2000; 13 (e_1_3_2_22_2) 2000; 474 (e_1_3_2_19_2) 1992; 301 (e_1_3_2_11_2) 1999; 158 (e_1_3_2_21_2) 1994; 15 (e_1_3_2_18_2) 1987; 15 (e_1_3_2_41_2) 1998; 19 (e_1_3_2_8_2) 1997 e_1_3_2_38_2 (e_1_3_2_15_2) 1995; 89 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_39_2 (e_1_3_2_4_2) 1995; 56 (e_1_3_2_35_2) 2001; 3 (e_1_3_2_13_2) 1986; 83 (e_1_3_2_12_2) 1998; 19 (e_1_3_2_43_2) 1997; 51 (e_1_3_2_10_2) 1995; 134 e_1_3_2_33_2 (e_1_3_2_20_2) 1998; 148 (e_1_3_2_30_2) 1997; 56 (e_1_3_2_25_2) 1999; 30 (e_1_3_2_26_2) 1996; 90 (e_1_3_2_28_2) 1998; 58 (e_1_3_2_3_2) 1996; 67 (e_1_3_2_29_2) 2001; 17 |
References_xml | – volume: 3 start-page: 150 year: 2001 ident: e_1_3_2_35_2 publication-title: Arch. Toxicol. – volume: 52 start-page: 880 year: 1999 ident: e_1_3_2_42_2 publication-title: J. Antibiot. doi: 10.7164/antibiotics.52.880 – ident: e_1_3_2_16_2 doi: 10.1056/NEJM199607113350202 – volume: 148 start-page: 288 year: 1998 ident: e_1_3_2_20_2 publication-title: Toxicol. Appl. Pharmacol. doi: 10.1006/taap.1997.8344 – volume: 56 start-page: 1151 year: 1995 ident: e_1_3_2_4_2 publication-title: Life Sci. doi: 10.1016/0024-3205(95)00055-B – volume: 259 start-page: 224 year: 1984 ident: e_1_3_2_9_2 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)43645-3 – volume: 13 start-page: 37 year: 2000 ident: e_1_3_2_37_2 publication-title: In vitro Mol. Toxicol. – volume: 12 start-page: 370 year: 1995 ident: e_1_3_2_32_2 publication-title: Drug Safety doi: 10.2165/00002018-199512060-00003 – volume: 56 start-page: 390 year: 1997 ident: e_1_3_2_30_2 publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.1997.56.390 – volume: 201 start-page: 383 year: 2000 ident: e_1_3_2_31_2 publication-title: Anat. Embryol. doi: 10.1007/s004290050326 – ident: e_1_3_2_33_2 doi: 10.4269/ajtmh.1999.60.547 – volume: 12 start-page: 683 year: 1996 ident: e_1_3_2_36_2 publication-title: Toxicol. Ind. Health doi: 10.1177/074823379601200507 – volume: 58 start-page: 28 year: 1998 ident: e_1_3_2_28_2 publication-title: Med. Trop. – volume: 88 start-page: 33 year: 1994 ident: e_1_3_2_5_2 publication-title: Trans. R. Soc. Trop. Med. Hyg. – volume: 45 start-page: 199 year: 1998 ident: e_1_3_2_14_2 publication-title: Brain Res. Bull. doi: 10.1016/S0361-9230(97)00339-0 – volume: 83 start-page: 313 year: 1986 ident: e_1_3_2_13_2 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.83.2.313 – volume: 24 start-page: 27 year: 1998 ident: e_1_3_2_34_2 publication-title: Med. – volume: 58 start-page: 22S year: 1998 ident: e_1_3_2_6_2 publication-title: Med. Trop. – start-page: 111 year: 1992 ident: e_1_3_2_24_2 publication-title: Selective neurotoxicity – volume: 90 start-page: 21 year: 1996 ident: e_1_3_2_26_2 publication-title: Ann. Trop. Med. Parasitol. doi: 10.1080/00034983.1996.11813022 – volume: 89 start-page: 447 year: 1995 ident: e_1_3_2_15_2 publication-title: Ann. Trop. Med. Parasitol. doi: 10.1080/00034983.1995.11812975 – ident: e_1_3_2_23_2 doi: 10.1126/science.3887571 – volume: 36 start-page: 1271 year: 1995 ident: e_1_3_2_44_2 publication-title: Investig. Ophthalmol. Vis. Sci. – volume: 67 start-page: 2484 year: 1996 ident: e_1_3_2_3_2 publication-title: J. Biochem. – volume: 301 start-page: 5 year: 1992 ident: e_1_3_2_19_2 publication-title: FEBS Lett. doi: 10.1016/0014-5793(92)80198-P – volume: 15 start-page: 6746 year: 1987 ident: e_1_3_2_18_2 publication-title: Nucleic Acids Res. doi: 10.1093/nar/15.16.6746 – ident: e_1_3_2_39_2 – volume: 22 start-page: 358 year: 1995 ident: e_1_3_2_2_2 publication-title: Clin. Exp. Pharmacol. Physiol. doi: 10.1111/j.1440-1681.1995.tb02015.x – start-page: 5 year: 1997 ident: e_1_3_2_8_2 publication-title: The role of oxidative stress in neuronal death – volume: 158 start-page: 2 year: 1999 ident: e_1_3_2_11_2 publication-title: Toxicol. Appl. Pharmacol. – volume: 15 start-page: 887 year: 1994 ident: e_1_3_2_21_2 publication-title: Neurotoxicology – ident: e_1_3_2_38_2 doi: 10.1007/BF03033326 – volume: 30 start-page: 636 year: 1999 ident: e_1_3_2_25_2 publication-title: Southeast Asian J. Trop. Med. Public Health – ident: e_1_3_2_27_2 – volume: 335 start-page: 69 year: 1996 ident: e_1_3_2_45_2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199607113350201 – volume: 17 start-page: 123 year: 2001 ident: e_1_3_2_29_2 publication-title: Trends Parasitol. – volume: 19 start-page: 393 year: 1998 ident: e_1_3_2_12_2 publication-title: Neurotoxicology – volume: 134 start-page: 1 year: 1995 ident: e_1_3_2_10_2 publication-title: Toxicol. Appl. Pharmacol. doi: 10.1006/taap.1995.1163 – volume: 15 start-page: 10070 year: 1987 ident: e_1_3_2_17_2 publication-title: Nucleic Acids Res. doi: 10.1093/nar/15.23.10070 – ident: e_1_3_2_40_2 doi: 10.1016/S0021-9258(18)54242-3 – volume: 19 start-page: 557 year: 1998 ident: e_1_3_2_41_2 publication-title: Neurotoxicology – volume: 51 start-page: 451 year: 1997 ident: e_1_3_2_43_2 publication-title: J. Antibiot. – ident: e_1_3_2_7_2 doi: 10.1016/S0140-6736(84)92457-7 – volume: 474 start-page: 238 year: 2000 ident: e_1_3_2_22_2 publication-title: FEBS Lett. doi: 10.1016/S0014-5793(00)01592-1 |
SSID | ssj0006590 |
Score | 2.0919383 |
Snippet | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit... We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell cultures (G.... ABSTRACT We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell... |
SourceID | pubmedcentral proquest crossref asm2 pubmed pascalfrancis highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 821 |
SubjectTerms | Adenosine Triphosphate - metabolism Animals Antimalarials Antimalarials - toxicity artemisinin Artemisinins Artemsisia Annua Biological and medical sciences Cell Survival Cells, Cultured Cytoskeleton - drug effects Cytoskeleton - metabolism Drug toxicity and drugs side effects treatment Energy Metabolism - drug effects Enzyme-Linked Immunosorbent Assay Lipid Peroxidation - drug effects Mechanisms of Action: Physiological Effects Medical sciences Membrane Potentials Mitochondria - drug effects Mitochondria - physiology Neurofilament Proteins - metabolism Neurons - drug effects Neurons - metabolism Neurotoxicity Syndromes Neurotoxicity Syndromes - pathology Neurotoxins Neurotoxins - toxicity Oxidative Stress - drug effects Pharmacology. Drug treatments Rats Reactive Oxygen Species - metabolism RNA - biosynthesis RNA - genetics Sesquiterpenes Sesquiterpenes - toxicity Toxicity: nervous system and muscle |
Title | Neurotoxic Mode of Action of Artemisinin |
URI | http://aac.asm.org/content/46/3/821.abstract https://www.ncbi.nlm.nih.gov/pubmed/11850267 https://journals.asm.org/doi/10.1128/AAC.46.3.821-827.2002 https://search.proquest.com/docview/18265817 https://pubmed.ncbi.nlm.nih.gov/PMC127487 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_WwsZexpZ9eVszP4wyWO3Y1qcfQ2jpNjLy0ELfhGTLNLA4ZU5h-e93kuWmGYNBHww2lixbP0l3Z_3uDuCTlszUEmda3ZgyobqsEm1yPJOVFtxym3tuzvwHP7-k367YVXAK6wKtsq3MMm1_rtJ2ee25lTerajLwxCaL-SxHU0qKyQEcCEIGCz2svpz1_1VQlGKDGQ1eO7gMT6bTWUp5SlJZ5IkshCcouKihKLNcIiZclXW3KvYl1BA12JEmdYf91vQJL_6lkf5NrLwnqc6ew7OgYsbT_lNewCPbjuBxn3RyO4In87CdPoLjRR-4ensSX-z8sLqT-Dhe7EJab1_CZx_DY7P-vaxilz0tXjfx1HtE-DPH1112LtXEK7g8O72YnSchx0KimRSbhGmNApzmeSOIKQ1e1ryoED9TyUxbUjba6EaKmpQ50RmtbMNLZnANtTnin5HXcNiuW_sWYlNkRnDDmK01paLRzJYiswZ1UlGjVhbBF9e9KkySTnn7o5AKcVGUK6IQFzyES41ZRJAOKKibPvDG_ypEA1YK21FaV3eFIhjvgbd7IkGLjxYigo8Dmgo7zG2a6Naub_El0f5iMscSb3psd3XDsImA76F-V8BF7t6_gwPaR_DuB_C7h1Z8D099UhpPhfsAh5tft_YIdaONGaNV8PX72E-JPys_Ceo |
link.rule.ids | 230,315,733,786,790,891,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD6CIS4vXMqAcNnygCYkljQX3_JYVUwF1qkPrbQ3y3YcUUHTiaQS5ddz4iQrnZAQPERyFDsX-7N9Tvz5OwBvlaA6F9jT8kJnAVGZCZSOMSWM4swyGztuzvSCTRbk0yW97DaFVR2tsjR6GZbfVmG5_OK4lVcrM-x5YsPZdByjKyX48Dbcwe6a0N5H78ZfRts_KziZ4iMj0u3bwYF4OBqNQ8LCNBRJHIiEO4pCoxuKs1YTignHZVWtkv05qtcNbmiTqsKaK9qQF3-ySW9SK3-bq84ewaL_ypai8jXc1Do0P28IQP5rNTyGh53x6o_aq0_gli0HcLcNZ7kdwL1pt1A_gJNZK4m9PfXnux1e1al_4s92Ytnbp_DOqYPU6x9L4zdx2fx14Y_cXguXapjAy6oJYnEIi7MP8_Ek6KI3BIoKXgdUKTQNSBwXPNWZxtOcJQaRoY2IlE2zQmlVCJ6nWZyqiBhbsIxqHJ1tjMiK0mdwUK5L-wJ8nUSaM02pzRUhvFDUZjyyGq1dnqO958H7ptlk1_0q6TybREhsb0mYTCW2Nx68CbqZeBD2rSuvWkmPvxXwegxIfI5Uylxn8uBoDxS7O6boS5KEe3Dco0RihTXLMaq06w2-JHp2VMSY43mLmV3ZDo4esD00XWdoNMH3ryBGnDZ4i4mX_1vwGO5P5tNzef7x4vMreOBC3zjC3Ws4qL9v7Bu0wGp95DrcLyYkKrM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4aQ0y8cCkMwmXLA5qQWO7xJY9VoRqXTn3YpPFk2Y4jKmha0VSi_HqOnWSlExLSHiIlih0n9mf7nPjzdwDeSE5UybGnlZUqglwWOpAqwTOuJaOGmsRxcybn9Owy_3RFrvaA93thHGlfq1lY_5iH9eyb41Yu5zrqeWLRdDJK0JXiLFqWVXQH7mKXTVnvp3djMCXt3xWcULHYOO_27uBgHA2HozCnYRbyNAkwp6MpWO1QnLlsOCYcm-Vqnu7OU712sKVOyhXWXtWGvfiXXXqTXvnXfDV-CF_7L21pKt_DdaNC_fuGCORtquIRPOiMWH_YpngMe6YewL02rOVmAAeTbsF-ACfTVhp7c-pfbHd6rU79E3-6Fc3ePIG3TiWkWfyaad_GZ_MXlT90ey7cmWUEz1Y2mMVTuBx_uBidBV0Uh0ASzpqASIkmQp4kFctUofCypKlGhCjNY2myopJKVpyVWZFkMs61qWhBFI7SJkGExdkh7NeL2jwHX6WxYlQRYkqZ56ySxBQsNgqtXlai3efBO9t0ouuGK-E8nJQLbHORU5EJbHM8mA2-mXoQ9i0slq20x_8yeD0OBJYjpNTXiTw42gHG9okZ-pR5yjw47pEisMLssoyszWKNL4keHuEJpnjW4mabt4OkB3QHUdcJrDb47h3EidMIb3Hx4rYZj-Fg-n4svnw8__wS7rsIOI539wr2m59r8xoNsUYduT73B56oLTM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurotoxic+Mode+of+Action+of+Artemisinin&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Schmuck%2C+G&rft.au=Roehrdanz%2C+E&rft.au=Haynes%2C+R+K&rft.au=Kahl%2C+R&rft.date=2002-03-01&rft.issn=0066-4804&rft.volume=46&rft.issue=3&rft.spage=821&rft.epage=827&rft_id=info:doi/10.1128%2FAAC.46.3.821-827.2002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon |